510 related articles for article (PubMed ID: 17060383)
1. Induction of oral tolerance to oxidized low-density lipoprotein ameliorates atherosclerosis.
van Puijvelde GH; Hauer AD; de Vos P; van den Heuvel R; van Herwijnen MJ; van der Zee R; van Eden W; van Berkel TJ; Kuiper J
Circulation; 2006 Oct; 114(18):1968-76. PubMed ID: 17060383
[TBL] [Abstract][Full Text] [Related]
2. Induction of oral tolerance to HSP60 or an HSP60-peptide activates T cell regulation and reduces atherosclerosis.
van Puijvelde GH; van Es T; van Wanrooij EJ; Habets KL; de Vos P; van der Zee R; van Eden W; van Berkel TJ; Kuiper J
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2677-83. PubMed ID: 17901374
[TBL] [Abstract][Full Text] [Related]
3. Vaccination using oxidized low-density lipoprotein-pulsed dendritic cells reduces atherosclerosis in LDL receptor-deficient mice.
Habets KL; van Puijvelde GH; van Duivenvoorde LM; van Wanrooij EJ; de Vos P; Tervaert JW; van Berkel TJ; Toes RE; Kuiper J
Cardiovasc Res; 2010 Feb; 85(3):622-30. PubMed ID: 19819882
[TBL] [Abstract][Full Text] [Related]
4. Role of naturally occurring CD4+ CD25+ regulatory T cells in experimental atherosclerosis.
Mor A; Planer D; Luboshits G; Afek A; Metzger S; Chajek-Shaul T; Keren G; George J
Arterioscler Thromb Vasc Biol; 2007 Apr; 27(4):893-900. PubMed ID: 17272749
[TBL] [Abstract][Full Text] [Related]
5. Lesion development and response to immunization reveal a complex role for CD4 in atherosclerosis.
Zhou X; Robertson AK; Rudling M; Parini P; Hansson GK
Circ Res; 2005 Mar; 96(4):427-34. PubMed ID: 15662027
[TBL] [Abstract][Full Text] [Related]
6. Induction of ovalbumin-specific tolerance by oral administration of Lactococcus lactis secreting ovalbumin.
Huibregtse IL; Snoeck V; de Creus A; Braat H; De Jong EC; Van Deventer SJ; Rottiers P
Gastroenterology; 2007 Aug; 133(2):517-28. PubMed ID: 17681173
[TBL] [Abstract][Full Text] [Related]
7. Oral anti-CD3 antibody treatment induces regulatory T cells and inhibits the development of atherosclerosis in mice.
Sasaki N; Yamashita T; Takeda M; Shinohara M; Nakajima K; Tawa H; Usui T; Hirata K
Circulation; 2009 Nov; 120(20):1996-2005. PubMed ID: 19884470
[TBL] [Abstract][Full Text] [Related]
8. CD4+LAP + and CD4 +CD25 +Foxp3 + regulatory T cells induced by nasal oxidized low-density lipoprotein suppress effector T cells response and attenuate atherosclerosis in ApoE-/- mice.
Zhong Y; Wang X; Ji Q; Mao X; Tang H; Yi G; Meng K; Yang X; Zeng Q
J Clin Immunol; 2012 Oct; 32(5):1104-17. PubMed ID: 22552859
[TBL] [Abstract][Full Text] [Related]
9. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets.
Pyzik M; Piccirillo CA
J Leukoc Biol; 2007 Aug; 82(2):335-46. PubMed ID: 17475784
[TBL] [Abstract][Full Text] [Related]
10. Short-term treatment with anti-CD3 antibody reduces the development and progression of atherosclerosis in mice.
Steffens S; Burger F; Pelli G; Dean Y; Elson G; Kosco-Vilbois M; Chatenoud L; Mach F
Circulation; 2006 Oct; 114(18):1977-84. PubMed ID: 17043169
[TBL] [Abstract][Full Text] [Related]
11. CD4+CD25+ T cells regulate the intensity of hypersensitivity responses to peanut, but are not decisive in the induction of oral sensitization.
van Wijk F; Wehrens EJ; Nierkens S; Boon L; Kasran A; Pieters R; Knippels LM
Clin Exp Allergy; 2007 Apr; 37(4):572-81. PubMed ID: 17430355
[TBL] [Abstract][Full Text] [Related]
12. Costimulation blockade-induced cardiac allograft tolerance: inhibition of T cell expansion and accumulation of intragraft cD4(+)Foxp3(+) T cells.
Oderup C; Malm H; Ekberg H; Qi Z; Veress B; Ivars F; Corbascio M
Transplantation; 2006 Dec; 82(11):1493-500. PubMed ID: 17164722
[TBL] [Abstract][Full Text] [Related]
13. Increased CD4+CD25+Foxp3+ regulatory T cells in tolerance induced by portal venous injection.
He F; Chen Z; Xu S; Cai M; Wu M; Li H; Chen X
Surgery; 2009 Jun; 145(6):663-74. PubMed ID: 19486771
[TBL] [Abstract][Full Text] [Related]
14. Suppression of early atherosclerosis in LDL-receptor deficient mice by oral tolerance with beta 2-glycoprotein I.
George J; Yacov N; Breitbart E; Bangio L; Shaish A; Gilburd B; Shoenfeld Y; Harats D
Cardiovasc Res; 2004 Jun; 62(3):603-9. PubMed ID: 15158153
[TBL] [Abstract][Full Text] [Related]
15. Influence of CD4+/CD25+ regulatory T cells on atherogenesis in patients with end-stage kidney disease.
Meier P; Meier R; Blanc E
Expert Rev Cardiovasc Ther; 2008 Aug; 6(7):987-97. PubMed ID: 18666849
[TBL] [Abstract][Full Text] [Related]
16. Oxidation of low-density lipoprotein cholesterol following administration of poloxamer 407 to mice results from an indirect effect.
Johnston TP; Zhou X
J Cardiovasc Pharmacol; 2007 Apr; 49(4):246-52. PubMed ID: 17438410
[TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of Foxp3(+) gammadelta T cells in mouse and human.
Kang N; Tang L; Li X; Wu D; Li W; Chen X; Cui L; Ba D; He W
Immunol Lett; 2009 Aug; 125(2):105-13. PubMed ID: 19539651
[TBL] [Abstract][Full Text] [Related]
18. Impact of plasma oxidized low-density lipoprotein removal on atherosclerosis.
Ishigaki Y; Katagiri H; Gao J; Yamada T; Imai J; Uno K; Hasegawa Y; Kaneko K; Ogihara T; Ishihara H; Sato Y; Takikawa K; Nishimichi N; Matsuda H; Sawamura T; Oka Y
Circulation; 2008 Jul; 118(1):75-83. PubMed ID: 18559699
[TBL] [Abstract][Full Text] [Related]
19. Antibodies to oxidized low density lipoprotein: epidemiological studies and potential clinical applications in cardiovascular disease.
Gounopoulos P; Merki E; Hansen LF; Choi SH; Tsimikas S
Minerva Cardioangiol; 2007 Dec; 55(6):821-37. PubMed ID: 18091649
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic islets induce CD4(+) [corrected] CD25(-)Foxp3(+) [corrected] T-cell regulated tolerance to HY-mismatched skin grafts.
Yoon IH; Choi SE; Kim YH; Yang SH; Park JH; Park CS; Kim Y; Kim JS; Kim SJ; Simpson E; Park CG
Transplantation; 2008 Nov; 86(10):1352-60. PubMed ID: 19034003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
